SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001008848-16-000096
Filing Date
2016-05-06
Accepted
2016-05-06 17:08:50
Documents
51
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q report_quarterly-033116.htm 10-Q 659054
2 CEO CERTIFICATION exhibit_31-1.htm EX-31.1 14846
3 CFO CERTIFICATION exhibit_31-2.htm EX-31.2 14833
4 CEO CERTIFICATION exhibit_32-1.htm EX-32.1 6671
5 CFO CERTIFICATION exhibit_32-2.htm EX-32.2 6627
  Complete submission text file 0001008848-16-000096.txt   3362206

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acor-20160331.xml EX-101.INS 555600
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acor-20160331.xsd EX-101.SCH 25957
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acor-20160331_cal.xml EX-101.CAL 46452
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acor-20160331_def.xml EX-101.DEF 124402
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acor-20160331_lab.xml EX-101.LAB 358122
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acor-20160331_pre.xml EX-101.PRE 247151
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50513 | Film No.: 161629124
SIC: 2836 Biological Products, (No Diagnostic Substances)